Biosynth showcasing API capabilities at CPHI 2023 Barcelona

Staad, Switzerland: – Complex Chemical specialist manufacturer and developer Biosynth AG will be a prominent presence as an exhibitor in the API Zone of Europe’s leading pharma industry event, the CPHI 2023 trade expo, this year in Barcelona.

The Biosynth display, at Stand 6E40 in the Fira Barcelona Gran Via expo center, will particularly feature the activities and capabilities of its Complex Chemicals Division. The division’s Senior Director, Dr. Vicky Gibson, will lead the Biosynth team in Barcelona.

From first idea to finished product

“We are very excited to be heading for Barcelona,” said Dr. Gibson. “CPHI always provides us with a wonderful platform to showcase our now very extensive capabilities to handle all aspects of a complex project from first idea to finished product.”

Biosynth will also feature in CPHI’s Contract Services category for its capabilities in contract manufacturing and synthetic route design.

Biosynth’s displays and communications at CPHI will showcase its unrivalled research product portfolio and end-to-end manufacturing services, along with its abilities to deliver key reagents at scale and quality as part of its overall mission to streamline life sciences industry supply chains across Complex Chemicals, Peptides and Key Biologics.

About Biosynth

Biosynth is a supplier of critical materials, securing life science supply chains with global research, manufacturing, and distribution facilities. Supplying the pharmaceutical and diagnostic sectors; where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation.

With an unrivaled research product portfolio of over a million products and end-to-end manufacturing services, Biosynth’s expertise and capability spans Complex Chemicals, Peptides, and Key Biologics, all from one trusted partner.  Headquartered in Staad, Switzerland, Biosynth is owned amongst others by KKR, Ampersand Capital Partners, and management.

Find out more about Biosynth at www.biosynth.com

About CPHI Barcelona 2023

Now in its 34th year, CPHI continues as the flagship European annual trade show for pharma ingredients and partner sourcing, with a refreshed mission to be the industry’s main enabler for sustainability, whilst also being an environmentally and socially responsible event.

The sustainability agenda is partly reflected in the 2023 CPHI conference agenda, with emphasis on NextGen Biomanufacturing, Formulating the Future, Patient-Centric Development, and Creating a Circular Economy, along with Future Therapies, Manufacturing 4.0, Quality Management Fundamentals and BioProduction.

It is also reflected in the hybrid model that fuses a large physical expo with an online dimension to make networking and browsing easier and to extend the time frame of the event indefinitely.

For 2023, CPHI Barcelona is a three-day physical event opening October 24 at the Fira Barcelona Gran Via expo center, with the online dimension now accessible all year round.

The previous ‘seven shows in one’ format has now been replaced by a more integrated main CPHI event featuring exhibitor zones for Machinery & Equipment, Finished Dosage, Packaging & Drug Delivery, Contract Manufacturing & Services, APIs, Excipients, Integrated Pharma, Natural extracts, and Fine Chemicals.

CPHI Barcelona is organised by Informa Markets with further information at: https://www.cphi.com/europe/en/home.html

Resources

Click on Biosynth at CPHI Barcelona 2023 to see exhibitor profile.
Click on Biosynth End-to-End Manufacturing Services for Complex Chemicals for further information.